Ocober 19, 2015 By Samuel Ben Turay
Programme Manager of the National Leprosy and Tuberculosis Control Program (NLTCP) in the Ministry of Health and Sanitation has told Concord Times that the mycobacterium that causes tuberculosis (TB) is still putting on resistance against the Rifampin and Isoniazid drugs they have been administering to TB patients over the years.
Dr. Alie H. Wurie said the development was detected globally during the past three years, noting that the mycobacterium has been putting on resistance to some of the TB patients who failed to take the drugs on a regular basis despite they were prescribed by the World Health Organisation (WHO) for the treatment of TB patients.
He said they are still facing challenges in eliminating the bacteria in the country despite efforts made by the ministry and its health partners.
buy amitriptyline online nouvita.co.uk/wp-content/themes/twentynineteen/inc/new/amitriptyline.html no prescription
He said in 2013, 14% of TB patients were children and that they are still facing challenges in eliminating the virus in the country.
Dr. Wurie said the disease is caused by a type of bacterium called mycobacterium tuberculosis, adding that it is also a communicable disease that can easily spread from person to person, especially when a person with an active TB infection in their lungs coughs or sneezes with others inhaling.
Dr. Wurie was speaking to Concord Times yesterday at the Health Ministry’s conference room after their 2015 annual review meeting.
While expressing concern over the situation, the NLTCP programme manager encouraged the public to be using the Directly Observer Treatment Services (DOTS) centers across the country, including necessary precautionary measures to avert infection.
He also disclosed that the Health Ministry has DOTS centers in all the districts across the country.